camonsertib
roche
['camonsertib']
at 11:15am edt at #aacr23, hear ruth plummer talk about the safety &amp; efficacy of three parp inhibitors combined with the ataxia telangiectasia- and rad3-related kinase inhibitor camonsertib in patients with #solidtumors: #crukfunded #aacr23
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK